Related Experiment Videos

Systemic lupus erythematosus: a consideration for antimicrobial prophylaxis

Insights

Systemic lupus erythematosus (SLE) patients have a high risk of heart valve damage and bacterial endocarditis. Antibiotic prophylaxis is recommended for all SLE patients undergoing dental procedures to prevent this serious complication.

Area of Science:

  • Cardiology
  • Rheumatology
  • Infectious Diseases

Background:

  • Systemic lupus erythematosus (SLE) frequently causes endothelial damage to heart valves, mirroring rheumatic heart disease.
  • Bacterial endocarditis affects 1% to 4% of SLE patients, a higher incidence than seen with rheumatic heart disease.

Purpose of the Study:

  • To highlight the significant risk of bacterial endocarditis in patients with SLE.
  • To emphasize the need for preventive measures in at-risk SLE populations.

Main Methods:

  • Review of existing literature on SLE, heart valve disease, and bacterial endocarditis.
  • Comparison of endocarditis incidence in SLE patients versus those with rheumatic heart disease and prosthetic valves.

Main Results:

  • Endothelial heart valve damage occurs in 50% of SLE patients.
  • Bacterial endocarditis incidence in SLE patients exceeds that in rheumatic heart disease patients.
  • Current inability to precisely identify SLE patients at highest risk for endocarditis.

Conclusions:

  • All patients with SLE should be considered at risk for bacterial endocarditis.
  • Antibiotic prophylaxis, following American Heart Association guidelines, is recommended for SLE patients undergoing dental procedures with potential for bacteremia.

Related Concept Videos